The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved October 1998

Specific Treatments:

Breast cancer

Find Related Trials for The Following Conditions

General Information

Herceptin (trastuzumab) is used as a second- or third-line therapy for patients with metastatic breast cancer.